Shiwei Ruan Selected Research

polyethylene glycol(B1)- insulin

1/2018

Endogenous ornithine decarboxylase/polyamine system mediated the antagonist role of insulin/PEG-CMCS preconditioning against heart ischemia/reperfusion injury in diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shiwei Ruan Research Topics

Disease

1	Diabetes Mellitus 01/2018
1	Reperfusion Injury 01/2018
1	Ischemia 01/2018
1	Myocardial Infarction 01/2018
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017

Drug/Important Bio-Agent (IBA)

1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	polyethylene glycol(B1)- insulinIBA 01/2018
1	ethylglyoxal bis(guanylhydrazone) (EGBG)IBA 01/2018
1	carboxymethyl-chitosanIBA 01/2018
1	AcetyltransferasesIBA 01/2018
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2018
1	SpermidineIBA 01/2018
1	SpermineIBA 01/2018
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2018
1	Oxidoreductases (Dehydrogenase)IBA 01/2018
1	PolyaminesIBA 01/2018
1	PutrescineIBA 01/2018
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2017
1	QuercetinIBA 01/2017
1	Therapeutic UsesIBA 01/2017